M. Kathleen Behrens - Mar 31, 2022 Form 4 Insider Report for IGM Biosciences, Inc. (IGMS)

Role
Director
Signature
/s/ Misbah Tahir, by power of attorney
Stock symbol
IGMS
Transactions as of
Mar 31, 2022
Transactions value $
$1,399,987
Form type
4
Date filed
4/4/2022, 08:10 PM
Previous filing
Mar 15, 2022
Next filing
Jun 13, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IGMS Common Stock Award $0 +374 +16.46% $0.00 2.65K Mar 31, 2022 Direct F1
transaction IGMS Common Stock Purchase $1M +43.5K +37.9% $23.00 158K Apr 1, 2022 See footnote F2, F3
transaction IGMS Common Stock Purchase $200K +8.7K +41.19% $23.00 29.8K Apr 1, 2022 See footnote F2, F4
transaction IGMS Common Stock Purchase $200K +8.7K +41.19% $23.00 29.8K Apr 1, 2022 See footnote F2, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The amount reflects payment of a quarterly retainer in common stock pursuant to the Issuer's Outside Director Compensation Policy.
F2 The shares were purchased pursuant to an underwritten public offering of the Issuer's securities.
F3 The shares are held in the name of KBW 2005 Trust for which Reporting Person is the Trustee.
F4 The shares are held in the name of Non-Exempt Trust for Patrick R. Wilsey Under the Alfred S. Wilsey, Jr. Revocable Trust for which Reporting Person is a Trustee.
F5 The shares are held in the name of Non-Exempt Trust for Shannon K. Wilsey Under the Alfred S. Wilsey, Jr. Revocable Trust for which Reporting Person is a Trustee.